FRUTTAROLO, Francesca
 Distribuzione geografica
Continente #
NA - Nord America 3.001
EU - Europa 1.643
AS - Asia 706
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 2
AF - Africa 1
OC - Oceania 1
Totale 5.357
Nazione #
US - Stati Uniti d'America 3.001
DE - Germania 783
CN - Cina 387
UA - Ucraina 273
TR - Turchia 191
RU - Federazione Russa 177
GB - Regno Unito 149
SG - Singapore 113
SE - Svezia 104
IT - Italia 65
FI - Finlandia 57
FR - Francia 13
BE - Belgio 6
CZ - Repubblica Ceca 4
IR - Iran 4
EU - Europa 3
LT - Lituania 3
NL - Olanda 3
HK - Hong Kong 2
IL - Israele 2
IN - India 2
PS - Palestinian Territory 2
AU - Australia 1
BR - Brasile 1
CL - Cile 1
EG - Egitto 1
GR - Grecia 1
IE - Irlanda 1
KR - Corea 1
PK - Pakistan 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 5.357
Città #
Woodbridge 434
Fairfield 321
Jacksonville 280
Ann Arbor 271
Houston 223
Chandler 206
Ashburn 166
Wilmington 156
Seattle 125
Beijing 93
Singapore 85
Cambridge 84
Izmir 81
Nanjing 80
Boardman 64
Princeton 61
Bremen 55
San Diego 38
Shanghai 35
Los Angeles 25
Nanchang 25
San Mateo 22
Shenyang 22
Changsha 20
Milan 18
Falls Church 16
Jiaxing 14
Philadelphia 14
Hebei 12
Kunming 12
New York 12
Tianjin 12
Santa Clara 11
Auburn Hills 9
London 9
Orange 9
Zhengzhou 9
Indiana 8
Jinan 8
Mountain View 8
Brussels 6
Helsinki 6
Dearborn 5
Guangzhou 5
Redwood City 5
Tappahannock 5
Bari 4
Kilburn 4
Ningbo 4
Norwalk 4
Ferrara 3
Florence 3
Haikou 3
Lanzhou 3
Redmond 3
Taizhou 3
Verona 3
Washington 3
Brno 2
Chiswick 2
Hangzhou 2
Hong Kong 2
Tel Aviv 2
Tulkarm 2
Walnut 2
Wandsworth 2
Yellow Springs 2
Acton 1
Bangor 1
Belgrade 1
Bologna 1
Bratislava 1
Caen 1
Chongqing 1
Clifton 1
Dehradun 1
Den Haag 1
Dublin 1
Düsseldorf 1
Fuzhou 1
Hefei 1
Kingston Upon Thames 1
Logan 1
Munich 1
New Bedfont 1
North Bergen 1
Olomouc 1
Patrocinio 1
Pietro 1
Prescot 1
Qingdao 1
Saint Petersburg 1
Tabriz 1
Taipei 1
Thessaloníki 1
Vilnius 1
Winter Park 1
Totale 3.273
Nome #
A synthetic approach for the preparation of rigid analogs of 1,3-dipropyl-7-methyl-8-aryl/heteroarylstyryl xanthines 156
Synthesis and biological effects of a new series of 2-amino-3-benzoylthiophenes as allosteric enhancers of A1-adenosine receptor 152
Synthesis and biological evaluation of 2-and 3-aminobenzo[b]thiophene derivatives as antimitotic agents and inhibitors of tubulin polymerization 141
Synthesis and preliminary biological evaluation of new anti-tubulin agents containing different benzoheterocycles 139
DNA minor groove binders as potential antitumor and antimicrobial agents 137
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2. 137
Hybrid molecules based on distamycin A as potential antitumor agents 133
Synthesis of a new series of pyrazolo[1,5-a]pyrimidines structurally related to zaleplon 132
Novel 8-heterocyclyl xanthine derivatives in drug development - An update 128
Synthesis and biological evaluation of 2-(3 ',4 ',5 '-trimethoxybenzoyl)-3-amino 5-aryl thiophenes as a new class of tubulin inhibitors 127
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2. 127
Pyrazolo [4,3-e][1,2,4]triazolo[1,5-c]pyrimidine template: Organic and medicinal chemistry approach 125
N-6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5 '-N-ethylearboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor 124
Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxyphenylsulfonyl)-5-aryl thiophenes as a new class of antitubulin agents 123
Recent improvements in the development of A2B adenosine receptor agonists. 123
null 120
Allosteric enhancers for A(1) adenosine receptor 116
Hybrid molecules between distamycin A and active moieties of antitumor agents 114
Recent improvements in the development of A2B adenosine receptor agonists 112
null 110
Synthesis of new pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines and related heterocycles 107
Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists 105
null 104
Recent developments in the field of adenosine receptor ligands. 103
Structure-activity relationships around the KN-62, a potent antagonist of the P2X(7)receptor 102
New 2-arylpyrazolo[4,3-c]quinoline derivates as potent and selective human A3 adenosine receptor antagonists 102
Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines and linked heterocycles as template for the adenosine receptor antagonism: medicinal chemistry approach and SAR considerations. 98
[H-3]-MRE 2029-F20, a selective antagonist radioligand for the human A(2B) adenosine receptors 98
Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine ligands, new tools to characterize A(3) adenosine receptors in human tumor cell lines 97
Synthesis and biological evaluation of novel N-6-[4-(substituted) sulfonamidophenylcarbamoyl]adenosine-5 '-uronamides as A(3) adenosine receptor agonists 96
Pharmacophore based receptor modeling: the case of adenosine A3 receptor antagonists. An approach to the optimization of protein models 95
Microwave-assisted synthesis of thieno[2,3-c]pyridine derivatives as a new series of allosteric enhancers at the adenosine A(1) receptor 94
Recent developments in the field of A(2A) and A(3) adenosine receptor antagonists 92
New strategies for the synthesis of A(3) adenosine receptor antagonists 92
Hybrid molecules containing benzo[4,5]imidazo[1,2-d][1,2,4]thiadiazole and alpha-bromoacryloyl moieties as potent apoptosis inducers on human myeloid leukaemia cells 91
Design, synthesis, and biological evaluation of C-9- and C-2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c] pyrimidines as new A(2A) and A(3) adenosine receptors antagonists 90
New pyrrolo[2,1-f]purine-2,4-dione and imidazo[2,1-f]purine-2,4-dione derivatives as potent and selective human A(3) adenosine receptor antagonists 89
Recent developments in the field of adenosine receptor ligands 86
New 2-arylpyrazolo[4,3-c]quinoline derivatives as potent and selective human A(3) adenosine receptor antagonists 83
null 82
Recent developments in the field of A2B and A3 adenosine receptors antagonists 82
O-SUBSTITUTED-DIBENZYL UREA-DERIVATIVES AS TRPV1 RECEPTOR ANTAGONISTS 79
Ligands for A(2B) adenosine receptor subtype 77
Recent improvements in the field of A(3) adenosine receptor ligands 77
New pyrrolo [2,1-f] purine-2,4-dione and Imidazo[2,1-f]purine-2,4-dione derivates as potent and selective human A3 adenosine receptor antagonists 75
Preparation of O-substituted-dibenzyl (thio)urea derivatives as TRPV1 receptor antagonists. 75
null 73
Preparation of isoquinolinyl cyclohexenylacrylamides as transient receptor potential vanilloid 1 (TRPV1) receptor antagonists 66
Synthesis and biological evaluation of new 8-heterocyclic xanthine derivative as highly potent and selective human A2B adenosine receptor antagonist 66
Preparation of N-aryl biarylcarboxamides as vanilloid-1 receptor modulators. 65
Preparation of O-substituted-dibenzyl urea derivatives as TRPV1 receptor antagonists. 58
Synthesis and biological evaluation of 2-amino-3-(3 ',4 ',5 '-trimethoxybenzoyl)-5-aryl thiophenes as a new class of potent antitubulin agents 25
Recent developments in the field of A(3) adenosine receptor antagonists 23
DNA minor-groove binders. Design, synthesis, and biological evaluation of ligands structurally related to CC-1065, distamycin, and anthramycin 22
Synthesis and biological evaluation of novel 1-deoxy-1-[6-[((hetero)arylcarbonyl)hydrazino]-9H-purin-9-yl]-N-ethyl-be ta-D-ribofuranuronamide derivatives as useful templates for the development of A(2B) adenosine receptor agonists 18
Pyrazolo-triazolo-pyrimidine derivatives as adenosine receptor antagonists: A possible template for adenosine receptor subtypes? 14
Totale 5.377
Categoria #
all - tutte 20.132
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.132


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020728 0 0 27 126 49 103 62 85 60 122 80 14
2020/2021596 103 69 15 69 19 68 14 67 11 62 72 27
2021/2022575 12 69 42 26 41 26 21 21 16 36 55 210
2022/2023545 53 6 10 70 144 86 6 43 82 3 26 16
2023/2024255 29 33 13 4 12 18 25 28 6 2 5 80
2024/2025159 20 47 92 0 0 0 0 0 0 0 0 0
Totale 5.377